APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lung Surfactants

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lung Surfactants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026181 pages

Choose your research edition.

Industry ResearchLung Surfactants Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Lung Surfactants Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Lung Surfactants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lung Surfactants Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lung Surfactants Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Lung Surfactants market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Lung Surfactants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lung Surfactants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lung Surfactants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lung Surfactants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lung Surfactants include Aviva Systems Biology Corporation, Chiesi Farmaceutici, Lyomark Pharma, ONY Biotech, Windtree Therapeutics and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lung Surfactants market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lung Surfactants and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lung Surfactants sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lung Surfactants market size, projected growth trends, production technologies, key applications, and end-use industries.

Lung Surfactants Segment by Company

Aviva Systems Biology Corporation

Chiesi Farmaceutici

Lyomark Pharma

ONY Biotech

Windtree Therapeutics

AbbVie

Lung Surfactants Segment by Type

Intratracheal

Injectable

Lung Surfactants Segment by Application

Special Clinic

Hospital

Recovery Center

Lung Surfactants Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung Surfactants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lung Surfactants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung Surfactants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lung Surfactants market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lung Surfactants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lung Surfactants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lung Surfactants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lung Surfactants Industry Trends Table 2. Lung Surfactants Industry Drivers Table 3. Lung Surfactants Industry Opportunities and Challenges Table 4. Lung Surfactants Industry Restraints Table 5. Global Lung Surfactants Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lung Surfactants Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lung Surfactants Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Lung Surfactants Sales Market Share by Manufacturers Table 9. Global Lung Surfactants Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Lung Surfactants Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lung Surfactants Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lung Surfactants Manufacturers, Product Type & Application Table 13. Global Lung Surfactants Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lung Surfactants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Intratracheal Table 17. Major Manufacturers of Injectable Table 18. Global Lung Surfactants Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Lung Surfactants Sales by Type (2021-2026) & (K Units) Table 20. Global Lung Surfactants Sales by Type (2027-2032) & (K Units) Table 21. Global Lung Surfactants Sales Market Share by Type (2021-2026) Table 22. Global Lung Surfactants Sales Market Share by Type (2027-2032) Table 23. Global Lung Surfactants Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Lung Surfactants Revenue by Type (2021-2026) & (K Units) Table 25. Global Lung Surfactants Revenue by Type (2027-2032) & (K Units) Table 26. Global Lung Surfactants Revenue Market Share by Type (2021-2026) Table 27. Global Lung Surfactants Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Special Clinic Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Recovery Center Table 31. Global Lung Surfactants Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Lung Surfactants Sales by Application (2021-2026) & (K Units) Table 33. Global Lung Surfactants Sales by Application (2027-2032) & (K Units) Table 34. Global Lung Surfactants Sales Market Share by Application (2021-2026) Table 35. Global Lung Surfactants Sales Market Share by Application (2027-2032) Table 36. Global Lung Surfactants Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Lung Surfactants Revenue by Application (2021-2026) & (K Units) Table 38. Global Lung Surfactants Revenue by Application (2027-2032) & (K Units) Table 39. Global Lung Surfactants Revenue Market Share by Application (2021-2026) Table 40. Global Lung Surfactants Revenue Market Share by Application (2027-2032) Table 41. Global Lung Surfactants Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Lung Surfactants Sales by Region (2021-2026) & (K Units) Table 43. Global Lung Surfactants Sales Market Share by Region (2021-2026) Table 44. Global Lung Surfactants Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Lung Surfactants Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Lung Surfactants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 48. North America Lung Surfactants Sales by Country (2027-2032) & (K Units) Table 49. Europe Lung Surfactants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 51. Europe Lung Surfactants Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Lung Surfactants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Lung Surfactants Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Lung Surfactants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Lung Surfactants Sales by Country (2027-2032) & (K Units) Table 58. Global Lung Surfactants Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Lung Surfactants Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Lung Surfactants Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Lung Surfactants Revenue Market Share by Region (2021-2026) Table 62. Global Lung Surfactants Revenue Market Share by Region (2027-2032) Table 63. Aviva Systems Biology Corporation Company Information Table 64. Aviva Systems Biology Corporation Business Overview Table 65. Aviva Systems Biology Corporation Lung Surfactants Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Aviva Systems Biology Corporation Lung Surfactants Product Portfolio Table 67. Aviva Systems Biology Corporation Recent Development Table 68. Chiesi Farmaceutici Company Information Table 69. Chiesi Farmaceutici Business Overview Table 70. Chiesi Farmaceutici Lung Surfactants Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Chiesi Farmaceutici Lung Surfactants Product Portfolio Table 72. Chiesi Farmaceutici Recent Development Table 73. Lyomark Pharma Company Information Table 74. Lyomark Pharma Business Overview Table 75. Lyomark Pharma Lung Surfactants Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Lyomark Pharma Lung Surfactants Product Portfolio Table 77. Lyomark Pharma Recent Development Table 78. ONY Biotech Company Information Table 79. ONY Biotech Business Overview Table 80. ONY Biotech Lung Surfactants Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. ONY Biotech Lung Surfactants Product Portfolio Table 82. ONY Biotech Recent Development Table 83. Windtree Therapeutics Company Information Table 84. Windtree Therapeutics Business Overview Table 85. Windtree Therapeutics Lung Surfactants Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Windtree Therapeutics Lung Surfactants Product Portfolio Table 87. Windtree Therapeutics Recent Development Table 88. AbbVie Company Information Table 89. AbbVie Business Overview Table 90. AbbVie Lung Surfactants Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. AbbVie Lung Surfactants Product Portfolio Table 92. AbbVie Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Lung Surfactants Distributors List Table 96. Lung Surfactants Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Lung Surfactants Product Image Figure 2. Global Lung Surfactants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lung Surfactants Market Size (2021-2032) & (US$ Million) Figure 4. Global Lung Surfactants Sales (2021-2032) & (K Units) Figure 5. Global Lung Surfactants Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Lung Surfactants Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Intratracheal Image Figure 9. Injectable Image Figure 10. Global Lung Surfactants Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Lung Surfactants Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Lung Surfactants Sales Market Share by Type (2021-2032) Figure 13. Global Lung Surfactants Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Lung Surfactants Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Lung Surfactants Revenue Market Share by Type (2021-2032) Figure 16. Special Clinic Image Figure 17. Hospital Image Figure 18. Recovery Center Image Figure 19. Global Lung Surfactants Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Lung Surfactants Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Lung Surfactants Sales Market Share by Application (2021-2032) Figure 22. Global Lung Surfactants Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Lung Surfactants Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Lung Surfactants Revenue Market Share by Application (2021-2032) Figure 25. North America Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Lung Surfactants Sales Market Share by Country (2021-2032) Figure 27. U.S. Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Lung Surfactants Sales Market Share by Country (2021-2032) Figure 32. Germany Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Lung Surfactants Sales Market Share by Country (2021-2032) Figure 39. China Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Lung Surfactants Sales Market Share by Country (2021-2032) Figure 47. Brazil Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Lung Surfactants Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Lung Surfactants Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Lung Surfactants Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Lung Surfactants Revenue (2021-2032) & (US$ Million) Figure 58. North America Lung Surfactants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Lung Surfactants Revenue (2021-2032) & (US$ Million) Figure 60. Europe Lung Surfactants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Lung Surfactants Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Lung Surfactants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Lung Surfactants Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Lung Surfactants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Lung Surfactants Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Lung Surfactants Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Intratracheal
  • Injectable
Applications
  • Special Clinic
  • Hospital
  • Recovery Center
Companies covered
  • Aviva Systems Biology Corporation
  • Chiesi Farmaceutici
  • Lyomark Pharma
  • ONY Biotech
  • Windtree Therapeutics
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lung Surfactants Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lung Surfactants Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lung Surfactants Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lung Surfactants Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lung Surfactants Market Dynamics
  1. 2.1 Lung Surfactants Industry Trends
  2. 2.2 Lung Surfactants Industry Drivers
  3. 2.3 Lung Surfactants Industry Opportunities and Challenges
  4. 2.4 Lung Surfactants Industry Restraints
3 Lung Surfactants Market by Manufacturers
  1. 3.1 Global Lung Surfactants Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lung Surfactants Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lung Surfactants Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lung Surfactants Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lung Surfactants Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lung Surfactants Manufacturers, Product Type & Application
  7. 3.7 Global Lung Surfactants Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lung Surfactants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lung Surfactants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lung Surfactants Tier 1, Tier 2, and Tier 3
4 Lung Surfactants Market by Type
  1. 4.1 Lung Surfactants Type Introduction
  2. 4.1.1 Intratracheal
  3. 4.1.2 Injectable
  4. 4.2 Global Lung Surfactants Sales by Type
  5. 4.2.1 Global Lung Surfactants Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lung Surfactants Sales by Type (2021-2032)
  7. 4.2.3 Global Lung Surfactants Sales Market Share by Type (2021-2032)
  8. 4.3 Global Lung Surfactants Revenue by Type
  9. 4.3.1 Global Lung Surfactants Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lung Surfactants Revenue by Type (2021-2032)
  11. 4.3.3 Global Lung Surfactants Revenue Market Share by Type (2021-2032)
5 Lung Surfactants Market by Application
  1. 5.1 Lung Surfactants Application Introduction
  2. 5.1.1 Special Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Lung Surfactants Sales by Application
  6. 5.2.1 Global Lung Surfactants Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lung Surfactants Sales by Application (2021-2032)
  8. 5.2.3 Global Lung Surfactants Sales Market Share by Application (2021-2032)
  9. 5.3 Global Lung Surfactants Revenue by Application
  10. 5.3.1 Global Lung Surfactants Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lung Surfactants Revenue by Application (2021-2032)
  12. 5.3.3 Global Lung Surfactants Revenue Market Share by Application (2021-2032)
6 Global Lung Surfactants Sales by Region
  1. 6.1 Global Lung Surfactants Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lung Surfactants Sales by Region (2021-2032)
  3. 6.2.1 Global Lung Surfactants Sales by Region (2021-2026)
  4. 6.2.2 Global Lung Surfactants Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lung Surfactants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lung Surfactants Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lung Surfactants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lung Surfactants Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lung Surfactants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lung Surfactants Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lung Surfactants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lung Surfactants Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lung Surfactants Revenue by Region
  1. 7.1 Global Lung Surfactants Revenue by Region
  2. 7.1.1 Global Lung Surfactants Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lung Surfactants Revenue by Region (2021-2026)
  4. 7.1.3 Global Lung Surfactants Revenue by Region (2027-2032)
  5. 7.1.4 Global Lung Surfactants Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lung Surfactants Revenue (2021-2032)
  8. 7.2.2 North America Lung Surfactants Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lung Surfactants Revenue (2021-2032)
  11. 7.3.2 Europe Lung Surfactants Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lung Surfactants Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lung Surfactants Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lung Surfactants Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lung Surfactants Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aviva Systems Biology Corporation
  2. 8.1.1 Aviva Systems Biology Corporation Company Information
  3. 8.1.2 Aviva Systems Biology Corporation Business Overview
  4. 8.1.3 Aviva Systems Biology Corporation Lung Surfactants Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aviva Systems Biology Corporation Lung Surfactants Product Portfolio
  6. 8.1.5 Aviva Systems Biology Corporation Recent Developments
  7. 8.2 Chiesi Farmaceutici
  8. 8.2.1 Chiesi Farmaceutici Company Information
  9. 8.2.2 Chiesi Farmaceutici Business Overview
  10. 8.2.3 Chiesi Farmaceutici Lung Surfactants Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Chiesi Farmaceutici Lung Surfactants Product Portfolio
  12. 8.2.5 Chiesi Farmaceutici Recent Developments
  13. 8.3 Lyomark Pharma
  14. 8.3.1 Lyomark Pharma Company Information
  15. 8.3.2 Lyomark Pharma Business Overview
  16. 8.3.3 Lyomark Pharma Lung Surfactants Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lyomark Pharma Lung Surfactants Product Portfolio
  18. 8.3.5 Lyomark Pharma Recent Developments
  19. 8.4 ONY Biotech
  20. 8.4.1 ONY Biotech Company Information
  21. 8.4.2 ONY Biotech Business Overview
  22. 8.4.3 ONY Biotech Lung Surfactants Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ONY Biotech Lung Surfactants Product Portfolio
  24. 8.4.5 ONY Biotech Recent Developments
  25. 8.5 Windtree Therapeutics
  26. 8.5.1 Windtree Therapeutics Company Information
  27. 8.5.2 Windtree Therapeutics Business Overview
  28. 8.5.3 Windtree Therapeutics Lung Surfactants Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Windtree Therapeutics Lung Surfactants Product Portfolio
  30. 8.5.5 Windtree Therapeutics Recent Developments
  31. 8.6 AbbVie
  32. 8.6.1 AbbVie Company Information
  33. 8.6.2 AbbVie Business Overview
  34. 8.6.3 AbbVie Lung Surfactants Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AbbVie Lung Surfactants Product Portfolio
  36. 8.6.5 AbbVie Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lung Surfactants Value Chain Analysis
  2. 9.1.1 Lung Surfactants Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lung Surfactants Production Mode & Process
  6. 9.2 Lung Surfactants Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lung Surfactants Distributors
  9. 9.2.3 Lung Surfactants Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst